These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2505290)

  • 41. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.
    Halliwell RF; Peters JA; Lambert JJ
    Br J Pharmacol; 1989 Feb; 96(2):480-94. PubMed ID: 2647206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of TCP on spatial memory: comparison with MK-801.
    Filliat P; Blanchet G
    Pharmacol Biochem Behav; 1995; 51(2-3):429-34. PubMed ID: 7667364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat.
    Gorter JA; de Bruin JP
    Brain Res; 1992 May; 580(1-2):12-7. PubMed ID: 1504791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems.
    Carlsson M; Svensson A
    Pharmacol Biochem Behav; 1990 May; 36(1):45-50. PubMed ID: 2161545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
    Schmidt WJ; Bubser M
    Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
    Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
    J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
    Ransom RW; Stec NL
    Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
    Csernansky JG; Martin M; Shah R; Bertchume A; Colvin J; Dong H
    Neuropsychopharmacology; 2005 Dec; 30(12):2135-43. PubMed ID: 15956997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impairment of the anterior thalamic head direction cell network following administration of the NMDA antagonist MK-801.
    Housh AA; Berkowitz LE; Ybarra I; Kim EU; Lee BR; Calton JL
    Brain Res Bull; 2014 Oct; 109():77-87. PubMed ID: 25307435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
    Herberg LJ; Rose IC
    Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NMDA antagonist MK-801 does not interfere with the use of spatial representation in a familiar environment.
    Uekita T; Okaichi H
    Behav Neurosci; 2005 Apr; 119(2):548-56. PubMed ID: 15839801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning.
    Wozniak DF; Brosnan-Watters G; Nardi A; McEwen M; Corso TD; Olney JW; Fix AS
    Brain Res; 1996 Jan; 707(2):165-79. PubMed ID: 8919293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spatial learning and goldfish telencephalon NMDA receptors.
    Gómez Y; Vargas JP; Portavella M; López JC
    Neurobiol Learn Mem; 2006 May; 85(3):252-62. PubMed ID: 16464619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
    Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NMDA receptor antagonists antagonize the facilitatory effects of post-training intra-basolateral amygdala NMDA and physostigmine on passive avoidance learning.
    Jafari-Sabet M
    Eur J Pharmacol; 2006 Jan; 529(1-3):122-8. PubMed ID: 16337625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of dizocilpine (MK-801) on flash-evoked potentials, body temperature, and locomotor activity of hooded rats.
    Hetzler BE; Burkard HK
    Pharmacol Biochem Behav; 1999 Mar; 62(3):559-73. PubMed ID: 10080251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of NMDA antagonists in the radial arm maze task with an interposed delay.
    Butelman ER
    Pharmacol Biochem Behav; 1990 Mar; 35(3):533-6. PubMed ID: 2160086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A single high dose of dizocilpine produces long-lasting impairment of the water maze performance in adult rats.
    Lukoyanov NV; Paula-Barbosa MM
    Neurosci Lett; 2000 May; 285(2):139-42. PubMed ID: 10793246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.